← FDA Drug Approvals (Drugs@FDA)

BUDESONIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIECURE PHARMA INC · Approved 2017-09-28

Drug application

FDA Application #
ANDA209041
Application type
Abbreviated New Drug Application (Generic)
Brand name
BUDESONIDE
Generic name
Budesonide
Active ingredients
BUDESONIDE
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Marketing status
Discontinued
Sponsor
SCIECURE PHARMA INC
First approval
2017-09-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown